Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Colgate-Palmolive's "epic run" higher may be about to normalize - Wells Fargo

Published 09/16/2024, 09:31 AM
© Reuters.
US500
-
KHC
-
KO
-
CL
-

Investing.com -- Shares in Colgate-Palmolive (NYSE:CL) hovered around the flatline in early US trading on Monday after analysts at Wells Fargo downgraded their rating of the toothpaste maker.

In a note to clients lowering their outlook to "Underweight" from "Equal Weight", the analysts argued that a recent "epic run" higher in the stock is set to see "normalization ahead."

New York-based Colgate-Palmolive's stock price has surged by more than 30% so far this year, buoyed in large part by a wider investor rotation into US consumer staples stocks that has been fueled by worries around a downturn in the US economy.

Drinks maker Coca-Cola (NYSE:KO), as well as other well-known sector players like Walmart (NYSE:WMT) and Kraft Heinz (NASDAQ:KHC), have outperformed the benchmark S&P 500 over six of the past eight weeks, according to Bloomberg data cited by the Financial Times.

For Colgate-Palmolive in particular, recent quarters have been marked by strong returns, with organic sales outperforming many of these big-name peers.

In July, the company also increased its organic sales and annual profit forecasts, citing resilient demand for its products despite a raft of recent inflation-linked price hikes. The higher prices have helped to offset an uptick in raw materials and packaging costs, supporting margins and backstopping an uptick in advertising spending.

Yet the analysts at Wells Fargo said Colgate-Palmolive's growth is now set to "normalize" versus its peers, while its global toothpaste share "may be on the verge of drifting lower."

Even still, they noted that they do not believe the firm is "broken," but on the cusp of its performance moderating against its rivals.

"After a cycle driven by accelerating organic sales, expanding gross margins, and strong investment back into advertising, we see [Colgate-Palmolive]'s delivery reverting to a more balanced model ahead. We still expect solid delivery, but with the stock historically expensive (absolute and relative to peers), we see risk of normalization (back to historicals) as valuation glides toward peers trading at much cheaper multiples," the analysts said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.